Literature DB >> 8380486

Time course of distant effects of local injections of botulinum toxin.

C G Garner1, A Straube, T N Witt, T Gasser, W H Oertel.   

Abstract

Botulinum toxin A (btx) is used to treat focal dystonias. From accidental intoxications it is known that btx can cause generalized pathologic single-fiber electromyography (SFEMG) findings. We monitored the onset and course of these disturbances in eight patients who received a small dose of btx (2-22 ng) for therapy of focal dystonias in the head/neck region for the first time via repeated SFEMG investigations at days 0, 3, 6, 9, 12, 28, and 56. Recordings were performed in the extensor digitorum brevis muscle, and in two patients additionally in the tibialis anterior muscle. In six of these patients we found an increase of jitter and blocking. The onset of these changes was in the range of 3-13 days after injection. Fiber density showed a tendency to increase. There was no correlation between SFEMG findings and the dose of injected btx. Possible mechanisms for these observations may be either a very efficient local uptake and retrograde axonal transport via the spinal motor neurons or a systemic distribution via the blood circulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380486     DOI: 10.1002/mds.870080106

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

Review 1.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.

Authors:  C Lorenzano; S Bagnato; F Gilio; G Fabbrini; A Berardelli
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  None detectable retrograde transport of Chinese botulinum toxin type A in mice by single intramuscular injection.

Authors:  Bin Hong; Lin-Lin Yao; Xing-Yue Hu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

6.  Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.

Authors:  Monika Rudzińska; Magdalena Wójcik; Andrzej Szczudlik
Journal:  J Neural Transm (Vienna)       Date:  2010-05-14       Impact factor: 3.575

Review 7.  Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

Authors:  Beth E Crowner; Diego Torres-Russotto; Alexandre R Carter; Brad A Racette
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

Review 8.  Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment.

Authors:  Alessio Baricich; Alessandro Picelli; Andrea Santamato; Stefano Carda; Alessandro de Sire; Nicola Smania; Carlo Cisari; Marco Invernizzi
Journal:  Clin Drug Investig       Date:  2018-11       Impact factor: 2.859

Review 9.  Therapeutic use of botulinum toxin in pain treatment.

Authors:  Raj Kumar
Journal:  Neuronal Signal       Date:  2018-08-31

Review 10.  Contribution of Single-Fiber Evaluation on Monitoring Outcomes Following Injection of Botulinum Toxin-A: A Narrative Review of the Literature.

Authors:  Hélène Moron; Corine Gagnard-Landra; David Guiraud; Arnaud Dupeyron
Journal:  Toxins (Basel)       Date:  2021-05-17       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.